|
|
||||||||
1 Center for Perinatal Biology, To test the hypothesis that variations in
cerebrovascular reactivity to 5-HT among arteries of different size or
type, during maturation, or during acclimatization to high altitude
involve differences in serotonergic receptor subtype, we determined
relative agonist potency orders and antagonist affinities in common
carotid (Com), main branch middle cerebral (Main), and
second branch middle cerebral (2BR) arteries from term fetal lambs and
nonpregnant adult sheep acclimatized at sea level or at an altitude of
3,820 m for
5-carboxamidotryptamine; 5-hydroxytryptamine types 1 and 2; 8-hydroxy-2(di-n-propylamino)tetraline; cerebral arteries; cerebrovascular circulation; GR-127935; hypoxia; ketanserin; maturation; methiothepin; SB-206553; sumatriptan; sheep
SEROTONIN'S MANY cerebrovascular effects include
responses of both physiological and pathophysiological importance.
Perivascular serotonergic nerves may help couple cerebral metabolism
and perfusion (5) and may also contribute to migraine (28). Serotonin
participates in cerebrovascular responses to aggregating platelets and
may also contribute to development of the vasospasm that typically follows intracranial hemorrhages (38). Although the exact role of
serotonin in many cerebrovascular responses remains under
investigation, its importance in the cerebral vasculature seems
certain.
Perhaps as a consequence of the many diverse cerebral functions of
serotonin, cerebrovascular reactivity to this agonist is not static and
instead can be modulated by many influences. Acclimatization to chronic
hypoxia alters cerebrovascular reactivity to serotonin and other amines
(26), as do pregnancy (20) and maturation (45). Cerebrovascular
reactivity to serotonin and other amines also varies in relation to
artery size and type (10, 45). Although the extent and nature of this
variability is well documented, the mechanisms responsible remain
unclear.
Aside from factors such as contractile protein content and
intracellular calcium pool size that govern overall contractile capacity, one of the most important determinants of arterial reactivity to any agonist is the receptor type to which it binds. Indeed, shifts
in receptor type are often closely associated with shifts in vascular
function. For example, the receptor mediating responses to
norepinephrine shifts from the
Serotonergic receptors at present are categorized into seven main
families, of which the 5-hydroxytryptamine types 1 and 2 (5-HT1 and
5-HT2, respectively) families most
commonly mediate contractile responses to 5-HT in vascular smooth
muscle (18, 19, 39). Within these two main receptor families, at least five different 5-HT1 subtypes and
three different 5-HT2 subtypes have been pharmacologically characterized and cloned (39). To examine
how these various 5-HT receptor types might vary with cerebral artery
type (or origin) and diameter, all experiments were carried out in
common carotid (Com), main branch middle cerebral arteries (Main), and
second branch order segments (2BR) of middle cerebral arteries. Owing
to its extracranial origin, the Com was expected to be more similar to
peripheral, than to cerebral, arteries. To examine how 5-HT receptor
type can vary with maturation, arteries from both term fetal lambs and
nonpregnant adult sheep were studied. To examine how hypoxic
acclimatization can influence 5-HT receptor type we also examined
arteries from nonpregnant adult sheep acclimatized at an altitude of
3,820 m for General
methods. For these studies, we
examined Com, Main, and 2BR arteries from adult rams and nonpregnant
ewes that had been maintained near sea level or at high altitude (3,820 m; Barcroft Laboratory, White Mountain Research Station, Bishop, CA)
for Briefly, after the initial dissection and removal of excess adipose and
connective tissue, we cut the arteries into individual ring segments
1-3 mm long. To avoid endothelial influences, we removed the
endothelium by mechanical abrasion achieved in Com and Main segments by
carefully passing a small needle through the lumen and in 2BR segments
by passing a human hair through the lumen of the vessels several times.
We then mounted the segments on paired tungsten wires (OD 250 µm for
Com, 125 µm for Main, and 24 µm for 2BR) between a low-compliance
force transducer (Kulite BG-10) and a post attached to a micrometer
used to vary resting tension. We equilibrated the arteries at
38.5°C (normal ovine core temperature) for at least 30 min in baths
superfused with a bicarbonate Krebs solution containing (in mM) 120 NaCl, 5.56 dextrose, 25.6 NaHCO3,
5.17 KCl, 2.49 MgSO4, and 1.60 CaCl2, in addition to 114 µM
ascorbic acid and 27 µM disodium EDTA. The baths were continuously
bubbled with 95% O2-5%
CO2. We obtained micrometer
readings for each segment under unstressed conditions (100 mg total
tension in Com and Main; 10 mg in 2BR) and calculated unstressed
diameter as twice the distance between the two wires divided by pi. For
2BR segments, optimum diameter was taken as 2.9 and 2.2 times
unstressed diameter in adult and fetal segments, respectively, which in
our previous studies has proven to be optimum in terms of both
reproducibility and maximum force generation (10). This extent of
stretch yielded resting tensions of After 30 min of equilibration at optimum stretch, we contracted all
arteries with a potassium-Krebs solution similar to that described
above, with the exception that NaCl was eliminated and exchanged for
KCl on an equimolar basis that yielded a final potassium ion
concentration of 120 mM. Exposure to potassium-Krebs was repeated until
reproducible maximal contractions were obtained, which generally required two or three exposures. The arteries were then contracted with
either 10 µM 5-HT (Com and Main) or UTP (2BR) segments. UTP was used
in the 2BR segments because it produced a much more stable contractile
response than that to 5-HT. Once agonist-induced tone had stabilized,
the arteries were then exposed to either 1 µM ADP (Com and Main) or 1 µM acetylcholine (2BR). ADP was used in Com and Main segments because
it is the most potent endothelium-dependent relaxant we have found in
these artery types. Correspondingly, acetylcholine was used in the 2BR
segments for similar reasons. Arteries of either type exhibiting
relaxations >10% to ADP or acetylcholine were discarded.
Agonist dose-response measurements.
After verification of endothelial denudation, the arteries were
equilibrated for another 30 min at optimum stretch in normal Krebs to
which we added 0.1 µM prazosin and 0.2 µM cocaine to block any
possible effect of Determination of antagonist
pKb values. In
preliminary experiments, 5-HT caused significant desensitization in
repeated concentration-effect determinations. To avoid this effect,
which violates classical Schild conditions, we determined antagonist
dissociation constants (pKb) by
comparing concentration-effect curves obtained from control and
antagonist treatments in paired adjacent artery segments. Owing to the
large number of antagonist-agonist combinations employed, tissue
availability could not accommodate allocation of more than one or two
artery segments from each animal to determination of each estimate of
antagonist affinity. Therefore,
pKb values were determined instead
of pA2 values, which require analysis of the effects of multiple concentrations of anatogonist using a Schild plot.
To normalize for segment-to-segment differences in contractile
capacity, all responses were normalized relative to the maximum response within each segment to 120 mM potassium-Krebs. Given the
reasonable assumption that equal magnitudes of response corresponded to
equal numbers of agonist-receptor interactions in adjacent segments
from the same artery, we then calculated equieffective dose ratios
between control and antagonist-treated segments at the
pD2 concentration of the
antagonist-treated segments. For this calculation, we determined
coefficients for the logistic equation for both control and
antagonist-treated arteries and then solved for the concentration in
the untreated control segments, which produced the tension observed at
the pD2 concentration in the
antagonist-treated segments. Because this approach meets the general
requirements necessary for a Schild analysis, we then used the
Furchgott equation to determine
pKb:
[A']/[A] = 1 + ([B]/KB) where
[A] is the concentration of agonist in the control tissues, [A'] is the concentration of agonist in the blocked
tissues at the pD2,
[B] is the concentration of antagonist, and
pKb is the Data analysis and statistics. The data
are expressed throughout the paper as means ± SE. Significant
differences in agonist potency
(pD2) and
Emax among 5-CT, 5-HT, 8-OH-DPAT,
and Suma were evaluated using ANOVA techniques followed by a Duncan's
multiple-range analysis. Given that pooled variances for common carotid
pD2 and Emax values were significantly
different than observed in the cerebral arteries (Main and 2BR), the
common and cerebral arteries were analyzed separately. Comparisons
between the different agonists were performed using the Duncan's
multiple-range analysis at the P < 0.05 level. Significant differences in antagonist affinities (pKb) were analyzed using
two-way ANOVAs with experimental group as one factor and artery type as
the other. Each antagonist was analyzed separately. Comparisons of
pKb values among experimental groups and among agonists were performed using a Duncan's post hoc
analysis. Unless indicated otherwise, statistical significance was
taken at the P < 0.05 level.
Drugs. The drugs used were 5-HT,
8-OH-DPAT, cocaine hydrochloride, prazosin, UTP, acetylcholine (all
from Sigma); methiothepin, ketanserin, 5-CT, and SB-206553 (all from
Research Biochemicals); and Suma and GR-127935 (supplied by Glaxco
Pharmaceuticals). Stock solutions of all drugs were made using
distilled water, were stored as aliquots at General results. From a total of 41 normoxic adults, 34 normoxic fetuses, and 29 hypoxic adults, a total of
380 Com, 313 Main, and 346 2BR artery segments were taken for study.
Com segment diameters averaged ~3.0 mm in adults and 2.6 mm in
fetuses. Main diameters averaged ~640 µm in adults and 470 µm in
fetuses. For 2BR segments, the diameters averaged 201 ± 3 µm in
normoxic adults, 197 ± 5 µm in hypoxic adults, and 203 ± 3 µm in normoxic fetuses. The maximal contractile tensions
produced by these arteries in response to 120 mM KCl averaged 6.2 ± 0.2 g in Com segments, 3.4 ± 0.1 g in Main segments, and
0.63 ± 0.01 g in 2BR segments. When precontracted with 1 µM 5-HT
(Com and Main) or 20 µM UTP (2BR), neither 10 µM ADP (Com and Main)
nor 1 µM acetylcholine (2BR) produced any significant vasodilatation,
indicating that endothelium removal was effective and complete.
Agonist potencies. In Com arteries,
the concentration-response curves for 5-CT and 8-OH-DPAT were
right-shifted relative to those for 5-HT (Fig.
1, Table 1).
Suma produced no significant contractile effect in Com segments from
any experimental group. As shown in Table 1, the relative order of
agonist potency was 5-HT > 5-CT and 5-HT > 8-OH-DPAT in Com
arteries from all experimental groups, although the relation between
5-CT and 8-OH-DPAT potency in the Com segments varied with group. Com
Emax values followed the same
general pattern observed for pD2:
5-HT > 5-CT and 5-HT > 8-OH-DPAT, with relation between 5-CT and
8-OH-DPAT varying among the different experimental groups (Table
2).
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
110 days. In normoxic adult Com segments, agonist
potency order was 5-hydroxytryptamine (5-HT) > 5-carboxamidotryptamine (5-CT)
8-hydroxy-2(di-n-propylamino)tetraline
(8-OH-DPAT); sumatriptan (Suma) produced no contractile response; and
antagonist dissociation constant
(pKb) values were
9.4 and 9.5 for ketanserin against 5-HT and 5-CT, 7.5 for GR-127935
against 5-HT, and 7.2 for SB-206553 against 5-HT. In normoxic adult
Main segments, agonist potency order was 5-HT > 5-CT
Suma
DPAT,
and pKb values were 9.1 and 9.2 for ketanserin against 5-HT and 5-CT and 7.4 and 8.5 for GR-127935 against 5-HT and Suma, respectively. In the 2BR segments from normoxic
adults, agonist potency order was 5-CT > 5-HT > Suma > DPAT and
pKb values were 7.4 and 7.2 for
ketanserin against 5-HT and 5-CT and 10.0 and 8.7 for GR-127935 against
5-HT and Suma, respectively. Compared with normoxic adults, none of
these values were significantly different in hypoxic adults and in
fetuses only the pKb values for
ketanserin against 5-HT in the 2BR segments (8.8) were greater. From
these results we propose that the ratio of
5-HT2 to
5-HT1 receptors is greatest in the
Com and decreases progressively to its smallest values in 2BR or
smaller segments. Because this gradient appears stable and relatively
resistant to the effects of maturation and chronic hypoxia, changes in
reactivity associated with these perturbations may involve alterations
in receptor density and/or coupling efficiency for 5-HT in
ovine cranial arteries.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
1-subtype in large arteries to
the
2-subtype in small arteries
(23, 24). Given the importance of receptor type in
determining reactivity, it is possible that changes in serotonergic
reactivity related to differences in artery size, type, age, and
hypoxic exposure could also be associated with shifts in receptor type.
The present experiments were conducted to evaluate these possibilities.
110 days. To identify the serotonergic receptors
involved in each of these experimental groups, we determined both
relative agonist potencies and antagonist affinities according to the
criteria established by Hoyer et al. (18, 19). With the use of these
approaches, we investigated the extent to which maturation, chronic
hypoxia, artery size, and artery type affect 5-HT receptor type in the
ovine cerebral circulation.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
110 days (arterial PO2
64 Torr) as well as near-term normoxic fetal sheep (139-141 days
gestation) using methods previously described (10, 33). Both males and
females were included in the normoxic fetus group, only nonpregnant
fully mature ewes (24 mo or older) were included in the hypoxic adult
group, and the normoxic adult group consisted mainly of nonpregnant
fully mature ewes with inclusion of a few young males (18-24 mo).
Statistical comparisons of basic characteristics, such as reactivity to
5-HT, maximum responses to potassium, and maximum responses to
endothelium-dependent vasodilators, as previously described (33), were
performed and verified that no significant differences existed
between animals of different sex.
150-250 mg. Com and Main
segments were stretched until resting tensions of 1.0 and 0.5 g were
attained, respectively. During all contractility experiments the
contractile tensions from all artery segments were continuously
recorded on both an ink-writing oscillograph (model 8373-20
recorder, Cole-Parmer Instrument) and an online computer, which
digitized and normalized the data.
1-receptors
and neuronal uptake, respectively. Thirty minutes later, cumulative
concentration-response curves were generated for 5-HT;
5-carboxamidotryptamine (5-CT), a preferential agonist of
5-HT1A and
5-HT1E receptors;
8-hydroxy-2(di-n-propylamino)tetraline (8-OH-DPAT), a preferential agonist of
5-HT1A receptors; and sumatriptan (Suma), a preferential agonist of the h1B and 1D serotonergic subtypes.
Each agent was added in half-log increments from 0.1 nM to 100 µM.
Each segment was used to determine only one concentration-response relation to only one agonist. On completion of the
concentration-response determinations, the contractile data were
normalized relative to the maximal response to potassium and then
fitted to the logistic equation using nonlinear regression to obtain
pD2 values (
log EC50) and the maximal
contractile responses (Emax) for
each agonist.
log
KB. In this manner, each estimate
of pKb was obtained from a matched
pair of artery segments, one treated with the antagonist and the other
served as the control. The antagonists used included the
5-HT2A-selective antagonist
ketanserin, the mixed
5-HT1/5-HT2 antagonist methiothepin, the
5-HTh1B- and
5-HT1D-selective antagonist GR-127935, and the selective
5-HT2B/5-HT2C
antagonist SB-206553.
20°C until time
of use, and were never frozen more than once.
![]()
RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

View larger version (20K):
[in a new window]
Fig. 1.
Concentration-response relations for 5-hydroxytryptamine (5-HT),
5-carboxamidotryptamine (5-CT),
8-hydroxy-2(di-n-propylamino)tetraline (DPAT), and
sumatriptan (Suma). Cumulative additions of 5-HT, 5-CT, 8-OH-DPAT, and
sumatriptan to common carotid (A),
main branch middle cerebral (B), and
second branch middle cerebral (C)
arteries of normoxic adult sheep yielded the concentration-response
relations indicated. All contractile responses are expressed as
%maximum responses to K+. Suma
produced no measurable response in common carotid segments from any
experimental group. All values are indicated as means ± SE, and
vertical error bars indicate SEs for the numbers of animals indicated
in Table 1.
Table 1.
Relative potencies of 5-HT receptor agonists in sheep arteries
Table 2.
Maximum responses to 5-HT receptor agonists in sheep arteries
In Main segments, the concentration-response curves for 5-CT,
8-OH-DPAT, and Suma were all right-shifted relative to those for 5-HT
(Fig. 1, Table 1). The relative order of agonist potencies was 5-HT > 5-CT
Suma
8-OH-DPAT in middle cerebral arteries from both the
normoxic and hypoxic adult groups but was different than this in Main
segments from normoxic fetuses: 5-HT
5-CT > Suma > 8-OH-DPAT (as
indicated in Table 1, > indicates significant differences at the
P < 0.05 level and
indicates no
significant difference and P > 0.05). In regard to Emax values in
Main segments, again the normoxic and hypoxic adult groups exhibited
identical patterns that were 5-HT > 5-CT > 8-OH-DPAT
Suma.
In the normoxic fetus group, this order was similar: 5-HT > 5-CT
8-OH-DPAT
Suma (Table 2).
In contrast to the Com and Main segments, concentration-response curves
for 5-HT, Suma, and 8-OH-DPAT were all right-shifted relative to those
for 5-CT in 2BR artery segments (Fig. 1, Table 1). In this artery
group, the relative order of agonist potencies was 5-CT > 5-HT > Suma > 8-OH-DPAT in normoxic adults, but was markedly
different in both hypoxic adults and normoxic fetuses: 5-CT
5-HT
Suma > 8-OH-DPAT. In 2BR artery segments, the relative order of
Emax values varied with
experimental group and exhibited the order 5-HT > 5-CT
8-OH-DPAT
Suma in normoxic adults, but in hypoxic adults the order was 5-HT > Suma
5-CT
8-OH-DPAT, which was similar to that observed in
normoxic fetuses: 5-HT > Suma
8-OH-DPAT
5-CT (Table 2).
For both 5-HT and 5-CT, agonist potencies increased progressively with the transition from Com to Main to 2BR in all experimental groups, although the magnitudes of these increases varied somewhat among the different groups. Similarly, Suma potencies also increased with the transition from Main to 2BR segments in all experimental groups. For 8-OH-DPAT, potencies did not vary consistently among artery types in the different experimental groups but tended to be least potent in Com segments and most potent in Main segments.
Antagonist affinities. As indicated in Fig. 2 and Table 3, ketanserin potently antagonized 5-HT-induced contractions, particularly in the Com segments where it exhibited subnanomolar affinities that did not vary significantly across the three experimental groups. Ketanserin pKb values against 5-HT in the Com segments were also slightly but not significantly greater than those in the Main segments in all experimental groups. Correspondingly, ketanserin pKb values within the Main segments did not vary with experimental group. In contrast, ketanserin pKb values within the 2BR segments were 2.5- to 50-fold less than those in the Main segments in all three groups, and this difference was significant in normoxic and hypoxic adults but not in normoxic fetuses. Within the 2BR segments, ketanserin pKb values were significantly greater in normoxic fetuses than in either adult group although the values within the adult groups did not differ significantly from one another.
|
|
Against 5-CT, ketanserin produced the same general pattern of results as that produced against 5-HT (Fig. 3 and Table 3). Ketanserin pKb values against 5-CT were in the subnanomolar range in all Com and Main segments, did not vary with experimental group in either artery type, and did not differ significantly between Com and Main segments within any experimental group. The ketanserin pKb values against 5-CT in the 2BR segments were all significantly lower than observed in Com and Main segments by at least 100-fold in all experimental groups. Within the 2BR segments, ketanserin pKb values against 5-CT did not vary with experimental group. It is important to note, however, that of eight experiments carried out to determine the pKb for ketanserin against 5-CT in fetal second branch segments, only three of these exhibited any effect. Against Suma-induced contractions, ketanserin had no measurable effect in any artery type from any experimental group.
|
Methiothepin affinities against 5-HT also exhibited a pattern similar to that observed for ketanserin (Fig. 2 and Table 3). Methiothepin pKb values against 5-HT were in the subnanomolar range in all Com and Main segments and did not differ significantly between Com and Main segments within any experimental group, although the values in the Main segments tended to be greater than those in the Com segments in all groups. Methiothepin pKb values did not differ significantly among the experimental groups in Com segments, but in Main segments the values obtained in normoxic fetuses were slightly but significantly less than observed in the normoxic adults. Methiothepin pKb values against 5-HT in the 2BR segments were all significantly less than in corresponding Main segments, and these differences averaged 25-fold in the normoxic adults, 8-fold in the hypoxic adults, but just 3-fold in the normoxic fetuses.
Against 5-CT, methiothepin affinities were more variable than observed against 5-HT (Fig. 3 and Table 3). In the Com segments, the pKb values were again in the subnanomolar range and did not vary significantly among the different experimental groups. In the Main segments, the pKb values were 5-fold less in normoxic adults, 3-fold greater in hypoxic adults, but 20-fold less in normoxic fetuses than observed in corresponding Com segments. Only the latter difference was statistically significant. Interestingly, methiothepin pKb values against 5-CT did not differ significantly between Main and 2BR segments in any experimental group and did not vary with experimental group in either artery type.
Consistent with observations made in other preparations (6, 25), both ketanserin and methiothepin exhibited some noncompetitive character against 5-HT and 5-CT (Figs. 2 and 3). These effects were most evident for methiothepin against 5-HT and 5-CT in the main branch middle cerebral but were also apparent for ketanserin against 5-CT in the main branch middle cerebral. In light of these effects, all calculations of pKb values were not based on pD2 shifts, which assume no effect on maximum response, but instead were based on dose-ratio analyses, which make no assumptions about possible effects on maximum response. These noncompetitive effects were not apparent in all arteries and were completely absent for the antagonists GR-127935 and SB-206553.
For the antagonist GR-127935, pKb values against 5-HT were low and ranged from 7.1 to 7.7 across all experimental groups (Figs. 2 and 4). These values did not differ significantly between artery types in any experimental group and also did not vary significantly with experimental group within any artery type. Against Suma, GR-127935 pKb values were somewhat greater and ranged from 7.5 to 8.5. However, again these values did not differ significantly between artery types in any experimental group and also did not vary significantly with experimental group within any artery type.
|
In the Com segments, the antagonist SB-206553 only weakly antagonized 5-HT-induced contractions, with pKb values averaging from 7.2 to 7.6 (Table 3). These values did not differ significantly among the three experimental groups.
| |
DISCUSSION |
|---|
|
|
|---|
The present experiments address the general hypothesis that changes in reactivity to 5-HT associated with maturation, acclimatization to chronic hypoxia, and differences in artery type involve differences in the receptor subtype mediating vasoconstrictor responses to 5-HT. As indicated by measurements of both relative agonist potency and antagonist affinity, the data suggest that 1) the receptors mediating responses to 5-HT changed from predominantly the 5-HT2a subtype in large Com arteries to a mixed 5-HT1/5-HT2 population in Main arteries to a predominantly 5-HT1 population in second branch segments of the middle cerebral arteries of adult sheep; 2) in small cerebral arteries the receptor mediating responses to 5-HT changed from a mixed 5-HT2/5-HT1-like population in term fetuses to a predominantly 5-HT1 population in adults; and 3) chronic hypoxia has little if any effect on 5-HT receptor type in adult carotid and cerebral arteries.
Serotonergic receptor type in ovine Com. In Com segments from all experimental groups, 5-HT was a more potent contractile agonist than 5-CT, 8-OH-DPAT, or Suma (Table 1). In addition, maximum contractile responses in the Com were far greater for 5-HT than any other agonist tested in all experimental groups (Table 2). Together, these data are consistent with the presence of the 5-HT2 receptor type according to the criteria of Hoyer et al. (18, 19). The absence of any contractile response to Suma, an agonist at the 1B, 1D, and 1F subtypes (2, 18, 19), suggests that these subtypes may not be present in the ovine Com. The low potency of 8-OH-DPAT further argues against the presence of the 1A subtype in Com segments, particularly in normoxic and hypoxic adults.
The subnanomolar affinities observed for ketanserin against 5-HT in Com
segments (Table 3) also suggest the presence of the 5-HT2 receptor type (18, 19).
Given that ketanserin generally exhibits near micromolar affinities
against most other serotonin receptors, the high affinity of ketanserin
against 5-CT observed in Com arteries suggests that these responses to
5-CT were mediated by action on
5-HT2 receptors. Consistent with
this interpretation, 5-CT exhibited low potency in the present
experiments (pD2
5.3) and in
other experiments has been shown to activate
5-HT2 receptors with low affinity
(pKi
4.7) (18).
Whereas ketanserin exhibits high affinity toward the
5-HT2 receptor, the antagonist
GR-127935 exhibits much lower affinities (pKi
7) toward this receptor
but much higher affinities toward the
5-HT1B and
5-HT1D subtypes
(pKi
9-10) (36). In the
present study, the affinities
(pKb) observed for GR-127935
against 5-HT ranged from 7.1 to 7.5 across all experimental groups,
thus again arguing in support of the presence of the
5-HT2 and against the 5-HT1B and
5-HT1D receptor types in ovine
Coms.
The methiothepin affinities observed were also consistent with the presence of the 5-HT2 receptor type in the ovine Com. Similar to ketanserin, methiothepin generally exhibits near nanomolar affinities for the 5-HT2 receptor, but unlike ketanserin, methiothepin also exhibits submicromolar affinities (7.7-8.1) against most 5-HT1 receptor types (18). The high pKb values observed for methiothepin against 5-HT (9.2-9.5) and also against 5-CT (9.1-9.9) are consistent with the presence of the 5-HT2 receptor type.
Given that the 5-HT2 family
includes three different subtypes (2A, 2B, and 2C), we used the
antagonist SB-206553 to help determine which of these subtypes were
present. As recently shown by Kennett et al. (21), this antagonist has
50- to 100-fold greater affinity toward the 2B and 2C subtypes
(pKi
9) than for the 2A
subtype (pKi
7.3). Thus the
relatively low pKb values
(7.2-7.6) obtained for SB-206553 against 5-HT in the Coms argue
against the presence of the 2B and 2C subtypes. Additional support for
this interpretation is provided by the finding that mRNA for the 2C
subtype is generally not found in extracranial tissues (1, 39).
Furthermore, the affinity for ketanserin against the 2B subtype is also
much lower (pKi
5-6) (22)
than observed in the present studies
(pKb
9). Together, the
combined agonist and antagonist data strongly suggest that contractile
responses to 5-HT in ovine Com arteries are mediated primarily by the
5-HT2A receptor subtype.
Serotonergic receptor type in ovine
Main. In the Main segments, the relative order of
agonist potencies was similar to that observed in the Com segments,
with the main exception that Suma produced significant contractile
responses, suggesting the presence of an additional receptor type
(Table 1), although the order of agonist potency was consistent with
the predominance of the 5-HT2
receptor type in Main segments (18). Another indication that a second
receptor type might be involved was provided by the observation that
5-CT potency was at least eightfold greater in Main segments than in
Com segments, across all experimental groups (Table 1). The potencies
observed for 5-CT (pD2
6.2-6.9), however, were still much lower than typically
observed for 5-CT at most 5-HT1
type receptors (7.9-8.6) (18), a result that might be expected if
5-CT were acting simultaneously with high affinity on
5-HT1 receptors and with low
affinity on 5-HT2 receptors.
Given that the 5-HT1A receptor is
rarely expressed in arterial smooth muscle (18, 39) and that the
potency observed for 8-OH-DPAT
(pD2
5.6-5.7) was
markedly less than typical of interaction at 1A receptors
(pD2
8.2), but was consistent
with interaction at other 5-HT1B,
5-HT1D, or
5-HT2 receptors
(pD2
5-7) (18), the data
were more consistent with the presence of the 1B or 1D subtype than
with the presence of the 1A subtype. To evaluate the possible presence
of the 1B/1D subtypes, pKb values
were measured for the antagonist GR-127935 against both 5-HT- and
Suma-induced contractions. Against 5-HT, these
pKb values ranged from 7.4 to 7.7, values much lower than typical of interaction of GR-127935 with 1B or
1D receptors (8.5-10) but were typical of interaction with the
5-HT2A subtype
(pKi
7.4) (36).
Against Suma, however, the affinities for GR-127935 were significantly
greater (8.1-8.5) than against 5-HT but were still too low to
suggest the presence of the human 1B
(pKi
9.9) or 1D
(pKi
8.9) receptor subtypes (36). Alternatively, the range of values observed was consistent with
the presence of the rat 1B receptor type
(pKi
8.5) (36). In further
support of this interpretation, the potencies observed for Suma
(pD2
5.9-6.4) were also
not typical of interaction with the 1D or h1B subtypes
(pD2
8.1-8.4) but were
compatible with the presence of the r1B subtype
(pD2
6.3) (30). Previous studies have also concluded that the
5-HT1B subtype is present in both
bovine and human middle cerebral arteries (14). Thus the combined
agonist and antagonist data are consistent with the interpretation that
contractile responses to 5-HT in ovine Main arteries are mediated by a
mixed population of 5-HT1
(possibly the r1B) and 5-HT2
receptors as previously suggested by Gaw et al. (13), and by Hamel et
al. (15) for cat cerebral arteries and by Parsons and Whalley (31) for
the rabbit basilar arteries.
Serotonergic receptor type in ovine
2BR. In contrast to the Com and Main arteries, 2BR
arteries from normoxic adults contracted with greatest sensitivity to
5-CT, and their relative order of agonist potencies was 5-CT > 5-HT > Suma > 8-OH-DPAT (Table 1). Although the results of statistical
comparisons among the different agonists varied somewhat with
experimental group, the same basic order of agonist potencies was
observed in all groups. This order suggests that the
5-HT1 type was predominant in 2BR
arteries. Consistent with this interpretation, ketanserin affinities
(Table 3) against 5-HT
(pKb = 7.4) and 5-CT
(pKb
7.2) in the normoxic adult second branch arteries were markedly less than typical of interaction at a 5-HT2 receptor
(pKb
9) and more
consistent with interaction at either a
5-HT1D
(pKi
7.4) (44) or a mixed population of 5-HT1B
(pKd
5.7) or
5-HT1A
(pKd
5.9) and
5-HT2 subtypes (17). In addition,
the mixed
5-HT1/5-HT2
antagonist methiothepin exhibited 16-fold greater affinity than
ketanserin against 5-HT and 8-fold greater affinity against 5-CT. The
methiothepin affinities observed against 5-HT
(pKb = 8.6) and 5-CT (8.1),
however, were much greater than their values at the 1A, 1B, or 1D
subtypes (pKd
7.1-7.3)
and slightly less than their affinity against the
5-HT2 subtype
(pKd
8.8). Together, these
data suggest the possible presence of a mixed
5-HT1/5-HT2
receptor population with predominance of the
5-HT1 subtype.
To help evaluate which 5-HT1
subtype was involved in 5-HT-induced contractions of the 2BR arteries,
we determined pKb values for the
antagonist GR-127935. The pKb
values obtained in second branch preparations from normoxic adults
against 5-HT (7.7) were much lower than typical of interactions with
the r1B (pKi
8.5), h1B
(pKi
9.9), or 1D
(pKi
8.9) receptors and were
much more typical of interaction with the
5-HT2A
(pKi
7.4) (36), again suggesting the possible presence of
5-HT2 receptors. Interestingly, the pKb values obtained for
GR-127935 against Suma (7.7) were identical to those obtained against
5-HT. Given that Suma has extremely low affinity toward the
5-HT2 receptor
(pKa
3.7-4.1) (35), it is unlikely that the contractions induced by Suma
(pD2
6.6) involved
5-HT2 receptors, and thus it seems
unlikely that the low pKb value
obtained for GR-127935 against Suma (7.7) was due to involvement of
5-HT2 receptors. Given that the
apparent affinity of GR-127935 was the same against 5-HT and Suma, it
remains possible that 5-HT and Suma activated the same receptor, as
previously proposed by Parsons and Whalley (31) based on similar
studies in the rabbit basilar artery. Although the nature of the
5-HT1 receptor involved in the
present studies remains uncertain, it is unlikely to be the 1A given
the low potency (pD2
5.6)
exhibited in 2BRs. In turn, the potency exhibited by Suma in the second branch preparations (pD2
6.6)
was more consistent with interaction at the r1B subtype
(pD2
6.3) than with the 1D or
h1B subtypes (pD2
8.1-8.4) (30). In either event, the overall data support the view
that contractile responses to 5-HT in 2BR arteries from normoxic adults
are mediated predominantly by
5-HT1 receptors (possibly the
r1B), with a possible contribution from a less dominant population of
5-HT2 receptors.
Effects of hypoxic acclimatization and maturation on 5-HT receptor type. A recurrent feature of many studies of the effects of high-altitude acclimatization include significant alterations in the reactivity of many vascular beds, a response we have demonstrated in the ovine cerebral circulation (26). Because receptor type is a key determinant of overall vasoreactivity, it seems reasonable to suspect that the receptor type mediating responses to 5-HT might change during high-altitude acclimatization. The present data, however, argue against this possibility. Aside from the typical (26) significant generalized increases in Emax that we observed in the Coms and Mains in hypoxic compared with normoxic adults (Table 2), there were no major differences in either agonist potencies (Table 1) or antagonist affinities (Table 3) between normoxic and hypoxic adults. Together these findings suggest that the changes in vascular reactivity associated with hypoxic acclimatization probably do not involve changes in receptor type, but rather changes in the coupling of the receptors to the contractile apparatus.
Compared with the general lack of effect of hypoxic acclimatization on
5-HT receptor type, maturation had a somewhat greater effect, which was
most pronounced in the 2BR artery segments. In the normoxic fetus, the
relative order of agonist potencies was essentially the same in the
second branch segments as observed in the normoxic adult (Table 1),
although maximum responses were somewhat depressed, particularly for
5-CT and 8-OH-DPAT. More importantly, ketanserin affinities against
5-HT were 25-fold greater in the fetus
(pKb
8.8) than in the adult
(pKb
7.4), suggesting much
greater 5-HT2 character in the
fetal second branch arteries (Table 3). Against 5-CT, ketanserin
affinities were also much less in the fetus
(pKb
6.7) than in the adult
(pKb
7.2), although this
difference was not significant. It is important to note, however, that
the majority (5 of 8) of attempts to determine the ketanserin
pKb against 5-CT yielded no
measurable effect, suggesting that the receptor type at which 5-CT and
ketanserin were interacting in the adult segments was either absent or
present only in reduced abundance in the fetus. Despite this
difference, no significant age-related differences in
pKb values were observed for any
other antagonist in the second branch segments. Overall, the combined agonist and antagonist data suggest that in the normoxic fetus, as in
the adult, contractile responses to 5-HT in the 2BR are mediated by a
mixed population of 5-HT1
(possibly the r1B) and 5-HT2
receptors and the relative proportion of
5-HT2 receptors is greater in the
fetus than in the adult.
In the Main segments from the fetus, the relative order of agonist
potencies was identical to that in the adult (Table 1), and the only
significant difference in antagonist affinities was that methiothepin
affinity against 5-HT was depressed in the fetus (pKb
9.3) relative to the
adult (pKb
10.0). In the Com
arteries, there were no age-related differences in antagonist
affinities (Table 3), but agonist potencies (Table 1) and maximum
responses (Table 2) tended to be generally greater in the fetus than
the adult, reflecting the well-established influence of maturation on
vasoreactivity (16, 33). These minor age-related differences not
withstanding, the overall distribution of serotonergic receptor subtypes was therefore basically the same in the fetus and adult, with
the exception that the second branch arteries exhibited greater 5-HT2 character in the fetus.
Physiological significance of shifts in serotonergic
receptor type. The present suggestion of a transition
from the 5-HT2a subtype in the
larger and more proximal Com, to a mixed 5-HT1/5-HT2 population with
5-HT2 predominance in the Main segments, to a mixed 5-HT1/5-HT2
population with 5-HT1 predominance in the 2BR is similar to patterns
suggested in other vascular beds. In rabbit aorta (9) and carotid
artery (43), 5-HT-induced contractions are mediated by the
5-HT2 receptor, whereas in the
smaller mesenteric (42) and basilar arteries (31), a mixed receptor
population of 5-HT2 and
5-HT1 receptors mediates responses
to 5-HT. At the level of the rabbit middle cerebral artery, the
responses to 5-HT are mediated predominantly by the
5-HT1-like and/or
5-HT1d receptor subtypes (8). In
addition, the distribution of
-adrenergic receptor subtypes has also
been shown to vary with artery diameter and tends to shift from the
1-subtype in larger arteries to
a mixed
1- and
2-population in intermediately
sized arteries, to predominantly the
2-subtype in terminal
arterioles (23, 24). The present findings are thus consistent with a
broad variety of evidence suggesting an artery size-related shift in
predominant receptor subtype.
A key difference among the characteristics of the receptors mediating
contractile responses to 5-HT in small and large arteries is the signal
transduction pathway involved. The
5-HT2 receptor involved in large
arteries is coupled to the synthesis and release of inositol
trisphosphate, which in turn stimulates the release of intracellular
calcium (34). The same is true of the
1-receptor type also
predominant in large arteries. In contrast, the
5-HT1 receptors present in small
arteries are coupled to decreases in cAMP, membrane depolarization, and
subsequent entry of calcium from the extracellular space (12, 37).
Again, the
2-receptor predominant in small arteries also uses a similar signal transduction pathway. Thus the receptor type in large arteries most typically stimulates the release of intracellular calcium, whereas the receptor type in small arteries typically stimulates the entry of extracellular calcium. Correspondingly, intracellular stores of calcium are generally
much greater and well developed in large than in small arteries (11).
Certainly, other factors related to artery size and type, such as
differences in electrophysiological characteristics (29), calcium
sensitivity (4), and cyclic nucleotide metabolism (32) may also in some
way influence and/or reflect different receptor distribution
among arteries of differing type and size. Nonetheless, the 5-HT
receptor type predominant in ovine cranial arteries appears closely
related to the relative dependence on intracellular release, compared
with extracelluar influx, as a source of activator calcium.
In parallel with the effects of changing artery size and type on receptor type, maturation further involves a generalized decreased reliance on extracellular calcium entry and an increased reliance on intracellular calcium release in many tissues (45). This general finding would predict that maturation would thus also involve a shift from the 5-HT1-like receptor type, which depends more on extracellular calcium entry, to the 5-HT2 type, which depends more on intracellular release. The fact that this shift was not observed, however, suggests at least three possibilities. First, the ability of Com and Main arteries to store and release intracellular calcium may be sufficient to mediate contractile responses to 5-HT in the term fetus. A second possibility is that the generally greater receptor densities typical of many receptor types in immature cerebral arteries (27) may in some way compensate for a decreased ability to release intracellular calcium. Third, the diacylglycerol released in tandem with inositol trisphosphate in response to 5-HT2 stimulation may play a more significant role in increasing extracellular entry (40, 41) and or increased calcium sensitivity (3) in the fetal compared with adult arteries. Consistent with this possibility, protein kinase C activity, which is stimulated by diacylglycerol, is generally greater in fetal than adult vascular tissues (7). At present, the relative importance of each of these possibilities remains uncertain, particularly in the 2BR artery segments where maturation appeared to decrease the presence of 5-HT2 receptors. Clearly, additional experiments will be required to differentiate among these possibilities.
Perspectives
The distribution of contractile 5-HT receptor types appears closely related to artery size and vascular bed of origin such that the ratio of 5-HT2 to 5-HT1 receptor densities is highest in the larger more proximal arteries and lowest in the smaller and more distal arteries of the ovine cerebral circulation. This pattern thus places the 5-HT2 receptor, which typically mobilizes intracellular calcium, predominantly in arteries containing the largest intracellular calcium stores (Com) and also places the 5-HT1 receptor, which is less dependent on intracellular calcium mobilization for contraction, predominantly in arteries with the smallest intracellular calcium stores (the 2BR). Given that this pattern of receptor distribution appears stable during maturation and hypoxic acclimatization, shifts in agonist potency and maximum response associated with these perturbations must be achieved through modulation of coupling efficiency and/or receptor density instead of changes in receptor type. How the observed patterns of 5-HT receptor distribution influence vasoreactivity, in vivo, however, remains somewhat uncertain because the present results were obtained in endothelium-denuded preparations and the endothelium may also be populated with 5-HT receptors of varying types (39) that potentially could be distributed in relation to artery type or size. Vasodilatory 5-HT receptors such as the 5-HT4 or 5-HT7 types (19, 39) might also contribute to integrated in vivo responses. Nonetheless, the present results emphasize that serotonergic receptor type in ovine cranial arteries varies in relation to the functional and morphological characteristics of different artery types but does not appear to change extensively during homeostatic adjustments to developmental or environmental change.| |
ACKNOWLEDGEMENTS |
|---|
The authors greatly appreciate the helpful comments of Dr. Edith Hamel regarding the interpretation of the data in this manuscript.
| |
FOOTNOTES |
|---|
The work reported here was supported by National Heart, Lung, and Blood Institute (NHLBI) Grant HL-54120 (to W. J. Pearce), National Institute of Child Health and Human Development Grant HD-31266 (to W. J. Pearce), NHLBI Grant HL-54094 (to L. Zhang), and the Loma Linda University School of Medicine.
Address for reprint requests: W. J. Pearce, Center for Perinatal Biology, Loma Linda Univ. School of Medicine, Loma Linda, CA 92350.
Received 28 July 1997; accepted in final form 12 May 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Abramowski, D.,
M. Rigo,
D. Duc,
D. Hoyer,
and
M. Staufenbiel.
Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera.
Neuropharmacology
34:
1635-1645,
1995[Medline].
2.
Adham, N.,
H. T. Kao,
L. E. Schecter,
J. Bard,
M. Olsen,
D. Urquhart,
M. Durkin,
P. R. Hartig,
R. L. Weinshank,
and
T. A. Branchek.
Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase.
Proc. Natl. Acad. Sci. USA
90:
408-412,
1993
3.
Akopov, S. E.,
L. Zhang,
and
W. J. Pearce.
Physiological variations in ovine cerebrovascular calcium sensitivity.
Am. J. Physiol.
272 (Heart Circ. Physiol. 41):
H2271-H2281,
1997
4.
Boels, P. J.,
M. Troschka,
J. C. Ruegg,
and
G. Pfitzer.
Higher Ca2+ sensitivity of triton-skinned guinea pig mesenteric microarteries as compared with large arteries.
Circ. Res.
69:
989-996,
1991
5.
Bonvento, G.,
E. T. MacKenzie,
and
L. Edvinsson.
Serotonergic innervation of the cerebral vasculature: relevance to migraine and ischaemia.
Brain Res. Brain Res. Rev.
16:
257-263,
1991[Medline].
6.
Chang, J. Y.,
and
C. Owman.
Cerebrovascular serotonergic receptors mediating vasoconstriction: further evidence for the existence of 5-HT2 receptors in rat and 5-HT1-like receptors in guinea-pig basilar arteries.
Acta Physiol. Scand.
136:
59-67,
1989[Medline].
7.
Das, M.,
K. R. Stenmark,
and
E. C. Dempsey.
Enhanced growth of fetal and neonatal pulmonary artery adventitial fibroblasts is dependent on protein kinase C.
Am. J. Physiol.
269 (Lung Cell. Mol. Physiol. 13):
L660-L667,
1995
8.
Deckert, V.,
D. Pruneau,
and
J. L. Elghozi.
Mediation by 5-HT1D receptors of 5-hydroxytryptamine-induced contractions of rabbit middle and posterior cerebral arteries.
Br. J. Pharmacol.
112:
939-945,
1994[Medline].
9.
De la Lande, I. S.
Evidence for a 5-HT1-like receptor mediating the amplifying action of 5-HT in the rabbit ear artery.
Br. J. Pharmacol.
107:
550-555,
1992[Medline]. 106: 1992, p. 550-555.]
10.
Elliott, S. R.,
and
W. J. Pearce.
Effects of maturation on
-adrenergic receptor affinity and occupancy in small cerebral arteries.
Am. J. Physiol.
267 (Heart Circ. Physiol. 36):
H757-H763,
1994
11.
Franco-Obergón, A.,
and
J. López-Barneo.
Differential oxygen sensitivity of calcium channels in rabbit smooth muscle cells of conduit and resistance pulmonary arteries.
J. Physiol. (Lond.)
491:
511-518,
1996[Medline].
12.
Garland, C. J.
The role of membrane depolarization in the contractile response of the rabbit basilar artery to 5-hydroxytryptamine.
J. Physiol. (Lond.)
392:
333-348,
1987
13.
Gaw, A. J.,
R. M. Wadsworth,
and
P. P. Humphrey.
Pharmacological characterisation of postjunctional 5-HT receptors in cerebral arteries from the sheep.
Eur. J. Pharmacol.
179:
35-44,
1990[Medline].
14.
Hamel, E.,
E. Fan,
D. Linville,
V. Ting,
J. G. Villemure,
and
L. S. Chia.
Expression of mRNA for the serotonin 5-hydroxytryptamine 1D beta receptor subtype in human and bovine cerebral arteries.
Mol. Pharmacol.
44:
242-246,
1993[Abstract].
15.
Hamel, E.,
J. P. Robert,
A. R. Young,
and
E. T. MacKenzie.
Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
J. Pharmacol. Exp. Ther.
249:
879-889,
1989
16.
Hayashi, S.,
M. K. Park,
and
T. J. Kuehl.
Relaxant and contractile responses to prostaglandins in premature, newborn and adult baboon cerebral arteries.
J. Pharmacol. Exp. Ther.
233:
628-635,
1985
17.
Hoyer, D.
5-Hydroxytryptamine receptors and effector coupling mechanisms in peripheral tissues.
In: The Peripheral Actions of 5-Hydroxytryptamine, edited by J. R. Fozard. Oxford: Oxford Medical, 1989, p. 72-99.
18.
Hoyer, D.,
D. E. Clarke,
J. R. Fozard,
P. R. Hartig,
G. R. Martin,
E. J. Mylecharane,
P. R. Saxena,
and
P. P. Humphrey.
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin).
Pharmacol. Rev.
46:
157-203,
1994[Abstract].
19.
Hoyer, D.,
and
G. R. Martin.
Classification and nomenclature of 5-HT receptors: a comment on current issues.
Behav. Brain Res.
73:
263-268,
1996[Medline].
20.
Hull, A. D.,
D. M. Long,
L. D. Longo,
and
W. J. Pearce.
Pregnancy-induced changes in ovine cerebral arteries.
Am. J. Physiol.
262 (Regulatory Integrative Comp. Physiol. 31):
R137-R143,
1992
21.
Kennett, G. A.,
M. D. Wood,
F. Bright,
J. Cilia,
D. C. Piper,
T. Gager,
D. Thomas,
G. S. Baxter,
I. T. Forbes,
P. Ham,
and
T. P. Blackburn.
In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties.
Br. J. Pharmacol.
117:
427-434,
1996[Medline].
22.
Kursar, J. D.,
D. L. Nelson,
D. B. Wainscott,
and
M. Baez.
Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor.
Mol. Pharmacol.
46:
227-34,
1994[Abstract].
23.
Langer, S. Z., and P. E. Hicks.
Alpha-adrenoceptors subtypes in blood vessels: physiology and
pharmacology. J. Cardiovasc.
Pharmacol. 6, Suppl.
4: S547-S558, 1984.
24.
Leech, C. J.,
and
J. E. Faber.
Different
-adrenoceptor subtypes mediate constriction of arterioles and venules.
Am. J. Physiol.
270 (Heart Circ. Physiol. 39):
H710-H722,
1996
25.
Lemoine, H.,
and
A. J. Kaumann.
Allosteric properties of 5-HT2 receptors in tracheal smooth muscle.
Naunyn Schmiedebergs Arch. Pharmacol.
333:
91-97,
1986[Medline].
26.
Longo, L. D.,
A. D. Hull,
D. M. Long,
and
W. J. Pearce.
Cerebrovascular adaptations to high-altitude hypoxemia in fetal and adult sheep.
Am. J. Physiol.
264 (Regulatory Integrative Comp. Physiol. 33):
R65-R72,
1993
27.
Longo, L. D.,
N. Ueno,
Y. Zhao,
L. Zhang,
and
W. J. Pearce.
NE-induced contraction,
1-adrenergic receptors, and Ins(1,4,5)P3 responses in cerebral arteries.
Am. J. Physiol.
270 (Heart Circ. Physiol. 39):
H915-H923,
1996
28.
MacKenzie, E. T.,
L. Edvinsson,
and
B. Scatton.
Functional bases for a central serotonergic involvement in classic migraine: a speculative view.
Cephalalgia
5:
69-78,
1985[Medline].
29.
Nelson, M. T.,
J. G. McCarron,
and
J. M. Quayle.
Ion channels in resistance arteries.
In: The Resistance Vasculature, edited by J. A. Bevan,
W. Halpern,
and M. J. Mulvany. Totowa, NJ: Humana, 1991, p. 265-279.
30.
Parker, E. M.,
D. A. Grisel,
L. G. Iben,
and
R. A. Shapiro.
A single amino acid difference accounts for the pharmacological distinctions between the rat and human 5-hydroxytryptamine 1B receptors.
J. Neurochem.
60:
380-383,
1993[Medline].
31.
Parsons, A. A.,
and
E. T. Whalley.
Evidence for the presence of 5-HT1-like receptors in rabbit isolated basilar arteries.
Eur. J. Pharmacol.
174:
189-196,
1989[Medline].
32.
Pearce, W. J.,
and
S. R. Elliott.
Maturation enhances the sensitivity of ovine cerebral arteries to the ATP-sensitive potassium channel activator lemakalim.
Pediatr. Res.
35:
729-732,
1994[Medline].
33.
Pearce, W. J.,
A. D. Hull,
D. M. Long,
and
L. D. Longo.
Developmental changes in ovine cerebral artery composition and reactivity.
Am. J. Physiol.
261 (Regulatory Integrative Comp. Physiol. 30):
R458-R465,
1991
34.
Roth, B. L.,
T. Nakaki,
D. M. Chuang,
and
E. Costa.
5-Hydroxytryptamine2 receptors coupled to phospholipase C in rat aorta: modulation of phosphoinositide turnover by phorbol ester.
J. Pharmacol. Exp. Ther.
238:
480-485,
1986
35.
Schoeffter, P.,
and
D. Hoyer.
How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors.
Naunyn Schmiedebergs Arch. Pharmacol.
340:
135-138,
1989[Medline].
36.
Skingle, M.,
D. T. Beattie,
D. I. Scopes,
S. J. Starkey,
H. E. Connor,
W. Feniuk,
and
M. B. Tyers.
GR127935: a potent and selective 5-HT1D receptor antagonist.
Behav. Brain Res.
73:
157-161,
1996[Medline].
37.
Sumner, M. J.,
W. Feniuk,
J. D. McCormick,
and
P. P. Humphrey.
Studies on the mechanism of 5-HT1 receptor-induced smooth muscle contraction in dog saphenous vein.
Br. J. Pharmacol.
105:
603-608,
1992[Medline].
38.
Szabo, C.,
K. Emilsson,
J. E. Hardebo,
S. Nystedt,
and
C. Owman.
Uptake and release of serotonin in rat cerebrovascular nerves after subarachnoid hemorrhage.
Stroke
23:
54-61,
1992
39.
Ullmer, C.,
K. Schmuck,
H. O. Kalkman,
and
H. Lubbert.
Expression of serotonin receptor mRNAs in blood vessels.
FEBS Lett.
370:
215-221,
1995[Medline].
40.
Wetzel, G. T.,
F. Chen,
W. F. Friedman,
and
T. S. Klitzner.
Calcium current measurements in acutely isolated neonatal cardiac myocytes.
Pediatr. Res.
30:
83-88,
1991[Medline].
41.
Wetzel, G. T.,
F. Chen,
and
T. S. Klitzner.
Na+/Ca2+ exchange and cell contraction in isolated neonatal and adult rabbit cardiac myocytes.
Am. J. Physiol.
268 (Heart Circ. Physiol. 37):
H1723-H1733,
1995
42.
Yildiz, O.,
and
M. Tuncer.
5-HT1-like and 5-HT2A receptors mediate 5-hydroxytryptamine-induced contraction of rabbit isolated mesenteric artery.
Naunyn Schmiedebergs Arch. Pharmacol.
352:
127-131,
1995[Medline].
43.
Yildiz, O.,
and
M. Tuncer.
Comparison of the effect of endothelium on the responses to sumatriptan in rabbit isolated iliac, mesenteric and carotid arteries.
Arch. Int. Pharmacodyn. Ther.
328:
200-212,
1994[Medline].
44.
Zgombick, J. M.,
L. E. Schechter,
S. A. Kucharewicz,
R. L. Weinshank,
and
T. A. Branchek.
Ketanserin and ritanserin discriminate between recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes.
Eur. J. Pharmacol.
291:
9-15,
1995[Medline].
45.
Zurcher, S. D.,
and
W. J. Pearce.
Maturation modulates serotonin- and potassium-induced calcium-45 uptake in ovine carotid and cerebral arteries.
Pediatr. Res.
38:
493-500,
1995[Medline].
This article has been cited by other articles:
![]() |
R. J. Sandoval, E. R. Injeti, W. T. Gerthoffer, and W. J. Pearce Postnatal maturation modulates relationships among cytosolic Ca2+, myosin light chain phosphorylation, and contractile tone in ovine cerebral arteries Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2183 - H2192. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Charles, L. Zhang, L. D. Longo, J. N. Buchholz, and W. J. Pearce Postnatal maturation attenuates pressure-evoked myogenic tone and stretch-induced increases in Ca2+ in rat cerebral arteries Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R737 - R744. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Pearce Hypoxic regulation of the fetal cerebral circulation J Appl Physiol, February 1, 2006; 100(2): 731 - 738. [Abstract] [Full Text] [PDF] |
||||